Webinars
Available On Demand
Trinity’s Diversity, Equity & Inclusion (DEI) strategy team invites life sciences executives to join a lively discussion on recent research and developments in clinical trial diversity with a focus on racial and ethnic minorities. Herman Sanchez, Chief Business Officer at Trinity Life Sciences, will host this session and moderate a panel with special guests Monique Marsh—Associate Director and Co-Head of Trinity’s Marketing Communications Insights COE, Julie Bayley—Associate Director in Trinity’s Insights practice and Ari King, Associate Consultant.
Key Topics
What…
Watch Now
White Papers
To date, life sciences’ efforts towards driving equitable healthcare have centered around access to care, early identification and prevention. Meanwhile, less attention has been given to the impact of the racial and ethnic homogeneity in trial populations. Clinical trial diversity continues to be one of the greatest challenges pharmaceutical and biotech companies face in ensuring the delivery of medicines that are effective for all people. Diverse clinical trial populations are an integral step in achieving equitable healthcare treatment.
While we…
Read Now
Podcasts
The importance of ensuring diversity in clinical trials is undisputed, but barriers across the healthcare ecosystem still exist; what can healthcare regulators, policy makers, and manufacturers do to overcome challenges when recruiting clinical trial participants?
Host, Matthew Rube, a Senior Consultant at Trinity Life Sciences, joins two of the subject-matter experts that authored Trinity Life Sciences’ cornerstone white paper to discuss why ensuring diversity in clinical trials participation is such a critical issue, the results of the team’s research, and…
Listen Now
White Papers
Providing optimal care to all patients is an imperative that unites the various, interconnected parts of the medical field, from primary care to the pharmaceutical industry to the work of large academic medical centers. Over the past 30 years, there have been exceptional advances in care, treatment, diagnostics, and early identification of disease. Unfortunately, even with these many technological advances, addressing the importance of diversity has been lagging. Since the advent of clinical trials, recruitment has been largely centered on…
Read Now
White Papers
Over the past few years, there has been a spotlight on gender representation in leadership in a wide range of industries. Women are underrepresented in healthcare and biotech companies, despite evidence showing that companies that don’t have equitable representation perform worse compared to those that do.
While this is recognized, there is a lack of understanding about the scope of the problem within life sciences consulting. In general, there is a lack of transparency on these issues, with a resulting…
Read Now
Webinars
Available On Demand
A diverse workforce signals competent management for investors and is a better reflection of your customers.” – VP, Commercial Operations
TGaS Advisors, a division of Trinity Life Sciences, partnered with EMD Serono to develop Company and Pipeline Development Scorecards from a benchmark study of life sciences compared to ex-industry best practice research, including surveys/interviews with 23 unique life science companies in the TGaS Client Network. Join us to hear findings from the study.
Key Webinar Topics
Why and how does…
Watch Now
Briefs
A life science company engaged TGaS Advisors to:
Investigate drivers for gender diversity in VP/SVP commercial roles
Benchmark high-performing companies (in/ex industry) with above-average numbers
of women in executive roles
Benchmark the key competencies and skills of women in executive commercial roles
Complete the form below to view the brief…
Read Now
